儿童新型冠状病毒感染诊断、治疗和预防专家共识(第四版)  

Diagnosis,treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children:experts′consensus statement(Fourth Edition)

作　　者：蒋荣猛 谢正德 姜毅[3] 陆小霞 金润铭[5] 郑跃杰[6] 尚云晓[7] 徐保平[8] 刘智胜[9] 卢根 邓继岿[11] 刘光华 王晓川[13] 王建设 冯录召 刘薇[16] 郑毅 舒赛男[18] 陆敏[19] 罗万军[20] 刘苗[3] 崔玉霞[21] 叶乐平 申阿东 刘钢[24] 高立伟[8] 熊莉娟 白燕[5] 林丽开 魏庄[27] 薛凤霞 王天有 赵东赤[29] 赵正言[30] 邵剑波[31] 吴国强 黄永坚[33] 李兴旺 杨永弘[6,23] 申昆玲 Jiang Rongmeng;Xie Zhengde;Jiang Yi;Lu Xiaoxia;Jin Runming;Zheng Yuejie;Shang Yunxiao;Xu Baoping;Liu Zhisheng;Lu Gen;Deng Jikui;Liu Guanghua;Wang Xiaochuan;Wang Jianshe;Feng Luzhao;Liu Wei;Zheng Yi;Shu Sainan;Lu Min;Luo Wanjun;Liu Miao;Cui Yuxia;Ye Leping;Shen Adong;Liu Gang;Gao Liwei;Xiong Lijuan;Bai Yan;Lin Likai;Wei Zhuang;Xue Fengxia;Wang Tianyou;Zhao Dongchi;Zhao Zhengyan;Shao Jianbo;Ng Daniel Kwok-keung;Wong Gary Wing-kin;Li Xingwang;Yang Yonghong;Shen Kunling(Diagnosis and Treatment Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China;Beijing Key Laboratory of Pediatric Respiratory Infection Diseases,Key Laboratory of Major Diseases in Children,Ministry of Education,National Clinical Research Center for Respiratory Diseases,Research Unit of Critical Infection in Children,Chinese Academy of Medical Sciences,2019RU016,Laboratory of Infection and Virology,Beijing Pe-diatric Research Institute,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health(Beijing),Beijing 100045,China;Department of Pediatrics,Renmin Hospital of Wuhan University,Wuhan 430060,China;Department of Respiratory,Wuhan Children′s Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430016,China;Department of Pediatrics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Respiratory,Shenzhen Children′s Hospital,Shenzhen 518038,China;Department of Pediatric Respiratory,Shengjing Hospital Affiliated to China Medical University,Shenyang 110004,China;Department of Respiratory,Beijing Children′s Hospital,Capital Medical University,National Cli-nical Research Center for Respiratory Diseases,National Center for Children′s Health(Beijing),Beijing 100045,China;Department of Neurology,Wuhan Children′s Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430016,China;Department of Respiratory,Guangzhou Women and Children′s Medica

机构地区：[1]首都医科大学附属北京地坛医院感染性疾病诊疗中心,北京100015 [2]国家儿童医学中心(北京),首都医科大学附属北京儿童医院,北京市儿科研究所,中国医学科学院儿童危重感染诊治创新单元,国家呼吸系统疾病临床医学研究中心,儿科重大疾病研究教育部重点实验室,儿童呼吸道感染性疾病研究北京市重点实验室,北京100045 [3]武汉大学人民医院儿科,武汉430060 [4]华中科技大学同济医学院附属武汉儿童医院呼吸科,武汉430016 [5]华中科技大学同济医学院附属协和医院儿科,武汉430022 [6]深圳市儿童医院呼吸科,深圳518038 [7]中国医科大学附属盛京医院小儿呼吸内科,沈阳110004 [8]国家儿童医学中心(北京),国家呼吸系统疾病临床医学研究中心,首都医科大学附属北京儿童医院呼吸科,北京100045 [9]华中科技大学同济医学院附属武汉儿童医院神经内科,武汉430016 [10]广州市妇女儿童医疗中心呼吸科,广州510623 [11]深圳市儿童医院感染科,深圳518038 [12]上海儿童医学中心福建医院,福建省儿童医院儿科,福州350005 [13]国家儿童医学中心(上海),复旦大学附属儿科医院临床免疫/过敏科,上海201102 [14]国家儿童医学中心(上海),复旦大学附属儿科医院感染传染科,上海201102 [15]中国医学科学院北京协和医学院群医学及公共卫生学院,北京100730 [16]天津大学儿童医院,天津市儿童医院,天津300134 [17]首都医科大学附属北京安定医院,国家精神心理疾病临床医学研究中心,精神疾病诊断与治疗北京市重点实验室,北京100088 [18]华中科技大学同济医学院附属同济医院儿科,武汉430030 [19]上海市儿童医院呼吸科,上海200062 [20]华中科技大学同济医学院附属武汉儿童医院感染管理办公室,武汉430016 [21]贵州省人民医院儿科,贵阳550002 [22]北京大学第一医院儿科,北京100034 [23]国家儿童医学中心(北京),国家呼吸系�

出　　处：《中华实用儿科临床杂志》2022年第14期1053-1065,共13页Chinese Journal of Applied Clinical Pediatrics

基　　金：国家自然科学基金(72174138);北京市卫健委高层次公共卫生技术人才建设项目(2022-2-002)。

摘　　要：自2019年12月以来,新型冠状病毒(SARS-CoV-2)感染在全球肆虐已2年余。我国始终采取科学有效的防控措施并取得一定成功,但随着SARS-CoV-2的不断变异和境外输入病例,导致疫情防控工作更加艰巨、复杂。随着变异株的变化,儿童病例数量也出现了变化,并且出现了一些新的特殊症候和并发症,这为我国儿童SARS-CoV-2感染的防治提出了新的课题。本共识在《儿童新型冠状病毒感染诊断、治疗和预防专家共识(第三版)》的基础上,根据新变异株的特点,对其病原学、病理学、发病机制等进行阐述,总结儿童病例的临床特点和诊疗经验,就儿童病例实验室检查、诊断、治疗和防控等提出建议,为进一步加强对我国儿童SARS-CoV-2感染的防治提供参考。Since December 2019,severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infections have raged globally for more than 2 years.China has always adopted scientific and effective prevention and control measures to achieved some success.However,with the continuous variation of SARS-CoV-2 cases and imported cases from abroad,the prevention and control work has become more difficult and complex.With the variation of the mutant strain,the number of cases in children changed,and some new special symptoms and complications were found,which proposed a new topic for the prevention and treatment of SARS-CoV-2 infection in children in China.Based on the third edition,the present consensus according to the characteristics of the new strain,expounded the etiology,pathology,pathogenesis,and according to the clinical characteristics and experience of children′s cases,and puts forward recommendations on the diagnostic criteria,laboratory examination,treatment,prevention and control of children′s cases for providing reference for further guidance of effective prevention and treatment of SARS-CoV-2 infection in children in China.

关 键 词：新型冠状病毒感染 儿童 诊断 治疗 预防 共识 

分 类 号：R725.6[医药卫生—儿科]